The US Food and Drug Administration (FDA) has granted more than $3.5m to various pediatric device consortia to encourage the development and availability of medical devices for children. This grants program is administered by the FDA's ...
Tags: Pediatric Medical Device, Medicine
Plexcera Therapeutics has received approval from Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine, to develop recombinant human acid ceramidase (rhAC) for treatment of diseases caused by genetic or ...
Tags: Plexcera, Cystic Fibrosis
Shire and Boston Children's Hospital have formed a three-year, broad research collaboration to develop new therapies to treat rare pediatric diseases. As part of the agreement, Shire will make an initial upfront payment to Boston ...
Tags: pediatric diseases, Children's Hospital, new therapies